About ACURX PHARMACEUTICALS INC
Early stage biopharmaceutical company focused on development of antibiotics that address difficult to treat bacterial infections. Acurx's approach to counter the emergence of antibiotic-resistant bacterial infections is to develop new antibiotics that effectively block an entirely new molecular target, DNA polymerase IIIC enzyme.
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to ACURX PHARMACEUTICALS INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.